Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

First Affiliated Hospital of Chongqing Medical University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
drug-repurposingimmunomodulation
hepatocellular carcinomas, resistance to immunotherapy, immunomodulation, drug repurposing, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836745
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.